Header Logo

Connection

CHITRA HOSING to Antigens, CD

Back to Details
This is a "connection" page, showing publications CHITRA HOSING has written about Antigens, CD.
CHITRA HOSING
Connection Strength
0.013
Antigens, CD
  1. Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. Leukemia. 2008 Feb; 22(2):258-64.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.